Combined oral upadacitinib and 308-nm excimer light for refractory progressive non-segmental vitiligo: A prospective observational study in 14 adults and 2 pediatric cases

Name: Combined oral upadacitinib and 308-nm excimer light for refractory progressive non-segmental vitiligo: A prospective observational study in 14 adults and 2 pediatric cases
Creator: wenyan liu
Published: 2025-08-07T15:47:39.381Z
Keywords: Vitiligo

liu, wenyan; liang, jingyao; Tang, Yaping

doi:10.17632/dz4cwrc68x.1

Combined oral upadacitinib and 308-nm excimer light for refractory progressive non-segmental vitiligo: A prospective observational study in 14 adults and 2 pediatric cases

Published: 7 August 2025| Version 1 | DOI: 10.17632/dz4cwrc68x.1

Contributors:

wenyan liu, jingyao liang, Yaping Tang

Description

VASI scores of 16 patients (adults and children) with progressive refractory non-segmental vitiligo treated with oral upadacitinib combined with 308-nm excimer light at 12, 16, 20, and 24 weeks.

Combined oral upadacitinib and 308-nm excimer light for refractory progressive non-segmental vitiligo: A prospective observational study in 14 adults and 2 pediatric cases

Description

Files

Categories

Licence